Polycystic Ovary Syndrome
|
|
- Chrystal Heath
- 6 years ago
- Views:
Transcription
1 Polycystic Ovary Syndrome An Individualized Approach Alice Y. Chang, MD, MSc Assistant Professor Mayo Clinic Division of Endocrinology, Diabetes, Nutrition and Metabolism
2 Learning Objectives: To Individualize or Personalize the Evaluation and Treatment of PCOS Review the diagnostic criteria for PCOS Understand how the criteria can guide management Select among treatment options Based on patient characteristics and desires Select among options to screen and treat co-morbidities of PCOS
3 Who are these women in your practice? Affects 6 to 8 % of women in the US Women with hirsutism Unwanted hair or hair loss Acne Women with infertility Women with irregular periods or amenorrhea Worried women told they have PCOS Azziz, R et al. JCEM 2004 As many as 20% by Rotterdam criteria Chang, AY et al. Clin Endo 2011
4 Breast cancer affects 1 in 8 women PCOS affects 1 in 5 women 2012 MFMER
5 Learning Objectives: To Individualize or Personalize the Evaluation and Treatment of PCOS Review the diagnostic criteria for PCOS Select among treatment options for hirsutism Select among options to screen and treat co-morbidities of PCOS
6 Case 1: 25 yo with Oligomenorrhea Do I have PCOS? Menarche age 12 Contraceptives: Birth control pill use age NuvaRing age Discontinued contraceptives x 8 months: Irregular periods every days Bleeds for 5-10 days, minimal cramping
7 Case 1: 25 yo with Oligomenorrhea PE: BMI 28 kg/m 2, BP 116/81 No cushingoid features Minimal acne over back Dark hair growth upper lip, upper/lower abdomen, upper/lower back, inner thighs No acanthosis nigricans
8 Ferriman-Gallwey 8 mild, > 15 moderate/severe MFMER
9 Case 1: Evaluation Question 1 What diagnostic biochemical testing to obtain? Prolactin TSH Total Testosterone Free Testosterone DHEA-S Androstenedione 17-OH Progesterone 24 hour urinary free cortisol Anti-mullerian hormone Day 21 progesterone Pelvic ultrasound?
10 Case 1: Evaluation Question 1 Established hirsutism and oligomenorrhea Prolactin TSH Total Testosterone Free Testosterone DHEA-S Androstenedione 17-OH Progesterone 24 hour urinary free cortisol Anti-mullerian hormone Day 21 progesterone Pelvic ultrasound? In addition to: pregnancy test, +/- FSH/LH
11 Case 1: Evaluation Question 1 No hirsutism, + oligomenorrhea? Prolactin TSH Total Testosterone Free Testosterone DHEA-S Androstenedione 17-OH Progesterone 24 hour urinary free cortisol Anti-mullerian hormone Day 21 progesterone Pelvic ultrasound?
12 Case 1: Evaluation Question 1 Hirsutism and regular menses? Prolactin TSH Total Testosterone Free Testosterone Day 3 DHEA-S Androstenedione 17-OH Progesterone 24 hour urinary free cortisol Anti-mullerian hormone Day 21 progesterone Pelvic ultrasound
13 Myth I need a pelvic ultrasound to diagnose PCOS False Misconception #1 The diagnosis of PCOS does not require documentation of polycystic ovaries They are really follicles not cysts 2012 MFMER
14 Case 1: 25 yo with Hirsutism and Oligomenorrhea Prolactin 12 ng/ml (N, < 20) TSH 1.7 miu/l (N, ) Total Testosterone 58 ng/dl (N, 8 60) DHEA-S 132 mcg/dl (N, ) 17-OH Progesterone 127 ng/dl Follicular <80 ng/dl Luteal <285 ng/dl
15 Case 1: Question for Audience Does this woman have PCOS? 1. Yes 2. No 3. It s unclear. We shouldn t treat her as if she has PCOS. 4. It s unclear. We can be comfortable treating her as if she has PCOS.
16 What is PCOS? 1. Hyperandrogenism The NIH Definition, the more severe phenotype - clinically (hirsutism) - OR elevated total testosterone 2. Irregular Menses (< 9 periods/yr) - since puberty or 20s Alopecia Acne Terminal Hair
17 What else is PCOS? Polycystic Ovaries one ovary with > 12 follicles, 2 to 10mm ultrasound OR ovarian volume > 10cc no cyst > 1cm 2014 AE-PCOS: transducer frequency 8MHz. At least one ovary containing 25 follicles
18 What else is PCOS? Insulin Resistance Insulin Resistance ~ 50%, even in lean Obesity Dyslipidemia Hypertension Acanthosis nigricans Metabolic Syndrome Syndrome XX
19 What are the 3 myths about the PCOS name? The diagnosis does not require having polycystic ovaries They are really follicles not cysts The ovary is not the cause of the syndrome 19
20 "The name PCOS is a News distraction Releasethat impedes Wednesday, January 23, 2013 progress. It is time to assign a name that reflects PANEL RECOMMENDS CHANGING NAME the complex interactions OF COMMON DISORDER IN WOMEN that characterize the syndrome." 2012 MFMER
21 Metabolic Reproductive Syndrome MRS JCEM, November 2013 ADA 2016 It is time to assign a new name that actually reflects the complex features of the condition, Helena J. Teede, MBBS, FRACP, PhD, professor and head of the Women s Public Health Research Program 2012 MFMER
22 Insulin Resistance, Pituitary, Ovary gonadotrophin release ovarian steroidogenesis Nestler, J. E. et al. N Engl J Med 1996;335:
23 Androgens Insulin resistance 2012 MFMER
24 Learning Objectives: To Individualize or Personalize the Evaluation and Treatment of PCOS Review the diagnostic criteria for PCOS Select among treatment options Select among options to screen and treat co-morbidities of PCOS
25 Case 1: Patient Question What treatment is right for me? What are you trying to treat? Hirsutism, irregular cycles, fertility?
26 Case 1: Question for Audience What would be your first approach to treating her excess hair growth? 1.Oral contraceptive 2.Oral contraceptive & spironolactone 3.Oral contraceptive & flutamide or finasteride 4. Metformin 5.Spironolactone & metformin 6.Oral contraceptive & spironolactone & metformin 7.Weight loss first 8.Laser therapy
27 Hirsutism guideline Endocrine Society First line, oral contraceptives Ovarian suppression AND increases SHBG? transvaginal estrogen as effective Consider anti-androgen after 6 months if suboptimal. Recommend against anti-androgen without adequate contraception. Data does not support use of insulin-lowering drugs for hirsutism. JCEM Vol. 93, issue 4, pg , MFMER
28 Hirsutism Therapy Ovarian suppression Suppresses ovarian androgen production Increases SHBG, decreases bioavailable T Resume menses, endometrial protection contraception Less androgenic progestin (19-Nor-Ts) Desogestrel, Norgestimate, Gestodene Drospirenone = AR Antagonist (Yasmin, Apri) GnRH Agonist: Rarely needed
29 Hirsutism Therapy Androgen Blockade Spironolactone really works! Start mg bid, check K, up to 100 mg BID Can increase in 3 month intervals Always combine with OCP Yasmin, Yaz, Desogen less Androgenic Cyproterone Acetate is the best Diana, Dianette not in USA Flutamide, Bicalutamide: Costly, Toxic Finasteride: $$
30 Hirsutism Therapy What To Expect Terminal hairs never go away Thinner hair shaft = less visible Longer telogen = less hairs at any time BEFORE laser or electrolysis, institute anti-androgen therapy to prevent new terminal hair SAVE MONEY $$$$
31 Treatment of Hirsutism Topical and Mechanical Plucking & shaving: Painful, iterative Waxing: less painful, more expensive Eflornithine (DFMO, Vaniqua ) ODC inhibitor, polyamine biosynthesis Slows rate of anagen phase Electrolysis: Very effective, expensive Laser: Very effective, expensive
32 Therapy: Adrenal Suppression Reserved for clearly documented 21OHD Partial replacement, not suppression In reality, glucocorticoid side effects occur before effect on hirsutism Anti-androgen, OCP Glucocorticoid treatment best reserved for infertility in Non-Classic Congenital Adrenal Hyperplasia
33 What is the best treatment for irregular menses in PCOS? 1.Oral contraceptive 2. Metformin 3.Weight loss
34 Myth or Reality In most cases, it s best to treat PCOS with oral contraceptives True False Misconception #2 OCP are not a treatment for PCOS per se Some women feel better off OCP OCP can worsen insulin sensitivity or increase blood pressure Alternatives exist for managing irregular menses 2012 MFMER
35 Case 1: Treatment of irregular cycles 1.Oral contraceptive 2. Metformin 3.Weight loss Fertility sooner and age close to 30 reproductive endocrine clomiphene, letrozole Fertility near future metformin NEJM, 2014 Fertility in more than a year oral contraceptives
36 Learning Objectives: To Individualize or Personalize the Evaluation and Treatment of PCOS Review the diagnostic criteria for PCOS Select among treatment options Select among options to screen and treat co-morbidities of PCOS
37 Case 2: 28 year-old with infertility Menarche age 11 with < 6 periods/year Age 16 diagnosed with PCOS Acne, progressive hirsutism (chin, upper lip, abdomen, arms (shaves, laser to face) On OCPs until one year ago Trying to conceive Has infrequent periods and gained 50 lbs Concerned about increased risk for diabetes Wants to get healthy before pregnancy
38 Case 2: 28 year-old with infertility Parents immigrated from Mexico. Mother and maternal grandmother with type 2 diabetes. Mother had a MI at age 45 Exam BMI 36 kg/m 2, BP125/77 Ferriman-Gallwey scale of hirsutism 12 Acne & mild acanthosis nigricans Laboratory data from primary MD Total testosterone 137 ng/dl Normal TSH & prolactin
39 Question for Audience How would you screen for insulin resistance in this woman? 1. 2 hour oral glucose tolerance test 2. Fasting glucose 3. Hemoglobin A1c 4. Fasting insulin 5. Fasting lipid panel
40 Misconception #3: I can test for insulin resistance Insulin resistance can only be defined when infusing insulin (i.e. clamp) Fasting insulin only helpful if high Hemoglobin A1c does not perform as well in PCOS For PCOS, recommendation is oral glucose tolerance test to detect impaired glucose tolerance MFMER
41 Diabetes Risk Assessment in PCOS Androgen Excess PCOS Society Recommendations: 2 hour 75 g oral glucose tolerance test BMI > 30 Lean PCOS over age 40 Gestational diabetes, family hx of type 2 diabetes NL: suggest every 2 yrs or new risk factors Wild et al. JCEM, 95(5): , 2010 Endocrine Society Recommendations: In all adolescents and women with PCOS HgbA1c if unable to complete OGTT Rescreen every 3 to 5 yrs or earlier if change Legro et al. JCEM, 98(12): , 2013
42 Importance of OGTT: IGT despite normal fasting glucose 2 hour Glucose Copyright 1999 The Endocrine Society Fasting Glucose Legro, R. S. et al. J Clin Endocrinol Metab 1999;84:
43 Higher Prevalence of Glucose Intolerance in 254 PCOS v. controls Percent (%) 16% 33% 0 7% Legro, R. S. et al. JCEM 1999 Copyright 1999 The Endocrine Society
44 Conversion to Diabetes and Impaired Glucose Tolerance 71 women with PCOS, 23 regular controls Percent (%) conversion Year 5 years control PCOS High Risk Legro, R. S. et al. J Clin Endocrinol Metab, 2005 Kjus, SL, et al. Diabetes, MFMER
45 Doctor, What is My Risk for Developing Diabetes? Higher than someone without PCOS Not as bad as other risk groups Personal history of gestational diabetes Family history of diabetes Ethnicity BMI 2012 MFMER
46 Which PCOS is riskier? NIH PCOS Phenotypes PCOS Features Androgen Excess Society Rotterdam (ESHRE/ASRM) Hyperandrogenism Oligo- or anovulation Polycystic ovaries CV Risk Factors Insulin resistance /- Obesity /- Dyslipidemia /- Adapted from Norman, RJ et al. Lancet, MFMER
47 PCOS is NOT associated with premature CV events or death PCOS deaths due to diabetes, not CV disease. UK PCOS, SMR Diabetes 4.60 ( ) No increase in CV events before : 7-fold modeled risk for MI 2011: 21 yrs later no increase in actual events 2012: Rochester Epidemiology Project Wild, Pierpoint, et. Al. Clin Endo, 2000 Dahlgren et al., Acta Ob Gyn Scand, 1992 Schmidt et. al. JCEM, 2011 Iftikhar et. al. Neth J Med, 2012
48 Increased CV risk with post-menopausal surrogates of PCOS Nurses Health Study very irregular menses RR 1.34 ( ) diabetes RR 3.86 ( ) Solomon, C, et. al. JAMA, 2001 Solomon, C, et. al. JCEM, 2002 Rancho-Bernardo elevated androgens, central adiposity, insulin resistance, irregular menses, infertility OR 1.36 ( ) WISE elevated androgens, irregular menses HR 1.59 ( ) Krentz, Menopause, 2007 Shaw et. al. JCEM, 2008
49 Summary: Evidence for PCOS and CV Risk Little evidence for premature events Greatest mortality risk may be from diabetes After menopause, associated risk factors persistence of elevated androgens metabolic syndrome obesity
50 Question for Audience Which co-morbidity would you screen for in this woman with PCOS, fatigue and family history of diabetes and cardiovascular disease? 1. Hyperlipidemia 2. Mood disorders 3. Cardiovascular disease 4. Obstructive sleep apnea 5. Fatty liver disease
51 Case 2: Lab Results Fasting glucose 97 mg/dl (N, ) 2 hour OGTT 140 mg/dl HbA1c 5.7% (N, %) Chol 211 mg/dl, trigs 322 mg/dl, HDL 42 mg/dl, LDL 140 mg/dl AST 60 U/L (N, < 48) ALT 50 U/L (N, < 75) Normal bilirubin & Alk Phos Sleep study: diagnosis of obstructive sleep apnea
52 Question for Audience What treatment approach would you recommend first? 1. Metformin 2. Statin 3. Weight loss 4. Bariatric surgery consult 5. CPAP 6. GI consult for a liver biopsy
53 Myth or Reality? I need to document impaired fasting glucose or impaired glucose tolerance to start metformin? True False 2012 MFMER
54 Treatments that Prevent Diabetes: Would Lifestyle win in PCOS? Metformin 31% Lifestyle 58% Diabetes Prevention Program, NEJM, 2002 Meta-analysis with 600+ PCOS, 40% reduction diabetes Salpeter, Am Journal Medicine, 2008
55 Indications for Metformin in PCOS For type 2 DM and pre-diabetes who fail lifestyle modification For women with menstrual irregularity who cannot take oral contraceptives Evidence for effect on metabolic consequences May assist in weight loss goals Legro et al. JCEM, 98(12): , 2013 You do not have to have pre-diabetes to see an effect 2012 MFMER
56 CHALLENGE QUESTION: Text page this am call gyn #55555 regarding PCOS pt 22 year old female with new onset hirsutism significant acne, never during adolescence 2 months ago started on oral contraceptives How long should we stop the oral contraceptives to test her androgens, how long? Which androgens to test? When should we consider adding on other therapies? 2012 MFMER
57 Take Home Points about PCOS Diagnostic Criteria Use Rotterdam but do not need all tests depending on history and physical Classic NIH criteria and androgen excess: associated with greater risk factors Treatment goals can guide your diagnosis Hirsutism Irregular menses/anovulation Risk factor reduction
58 Take Home Points about PCOS Treatment for Hirsutism First line, estrogens Estrogens > spironolactone > metformin Do no harm Not recommended: flutamide, finasteride/dutasteride, corticosteroids Lower androgen effect before definitive electrolysis/laser therapy
59 Take Home Points about PCOS Anovulatory cycles Metformin may help restore ovulatory cycles Closer to the age of 30, if fertility desired, refer for clomiphene Oral contraceptives if fertility not desired in near future. Take advantage of a window of 3 to 6 months after stopping oral contraceptives to conceive
60 Take Home Points about PCOS Co-morbidities assessment Screen for impaired glucose tolerance with a 2 hour OGTT Negative tests do not exclude insulin resistance HbA1c misses IGT Use acanthosis nigricans, family history, gestational history to increase or decrease risk factor status Use history and treatment goals to screen for other comorbidities
61 PCOS, astronauts and Mayo Clinic Astronaut Ophthalmic Issues and One Carbon Metabolism: Evaluation in Patients with Polycystic Ovary Syndrome and/or Idiopathic Intracranial Hypertension Contact ,
62 Suggested References Legro et al. Diagnosis and Treatment of Polycystic Ovary Syndrome: An Endocrine Society Clinical Practice Guideline. JCEM 98 (12): Evaluation and Treatment of Hirsutism in Premenopausal Women: An Endocrine Society Clinical Practice Guideline. JCEM 93 (5): , 2008 Loriaux, DL. An Approach to the Patient with Hirsutism. JCEM 97 (9): , Tang T et al. Insulin-sensitising drugs for women with polycystic ovary syndrome, oligo amenorrhoea and subfertility. Cochrane Database Syst Rev May 16 Wild et al. Assessment of Cardiovascular Risk and Prevention of Cardiovascular Disease in Women with the Polycystic Ovary Syndrome: A Consensus Statement by the Androgen Excess and Polycystic Ovary Syndrome (AE-PCOS) Society. JCEM, 95(5): , MFMER
Polycystic Ovary Syndrome HEATHER BURKS, MD OU PHYSICIANS REPRODUCTIVE MEDICINE SEPTEMBER 21, 2018
Polycystic Ovary Syndrome HEATHER BURKS, MD OU PHYSICIANS REPRODUCTIVE MEDICINE SEPTEMBER 21, 2018 Learning Objectives At the conclusion of this lecture, learners should: 1) Know the various diagnostic
More information12/13/2017. Important references for PCOS. Polycystic Ovarian Syndrome (PCOS) for the Family Physician. 35 year old obese woman
Polycystic Ovarian Syndrome (PCOS) for the Family Physician Barbara S. Apgar MD, MS Professor or Family Medicine University of Michigan Ann Arbor, Michigan Important references for PCOS Endocrine Society
More informationCase Questions. Polycystic Ovarian Syndrome: Treatment Goals and Options. Differential Diagnosis of Hyperandrogenic Anovulation
Polycystic Ovarian Syndrome: Treatment Goals and Options Marc Cornier, MD Division of Endocrinology, Metabolism and Diabetes Colorado Center for Health and Wellness University of Colorado School of Medicine
More informationDr Stella Milsom. Endocrinologist Fertility Associates Auckland. 12:30-12:40 When Puberty is PCO
Dr Stella Milsom Endocrinologist Fertility Associates Auckland 12:30-12:40 When Puberty is PCO Puberty or Polycystic Ovary Syndrome? Stella Milsom Endocrinologist Auckland DHB, University of Auckland,
More informationPolycystic Ovarian Syndrome. Heidi Hallonquist, MD Concord Hospital Concord Obstetrics and Gynecology
Polycystic Ovarian Syndrome Heidi Hallonquist, MD Concord Hospital Concord Obstetrics and Gynecology Outline Definition Symptoms Causal factors Diagnosis Complications Treatment Why are we talking about
More informationPolycystic Ovary Syndrome
Polycystic Ovary Syndrome Kathleen Colleran, MD Professor of Medicine University of New Mexico HSC Presented for COMM-TC May 4, 2012 Objectives Understand the pathophysiology of PCOS Understand how to
More informationWhat every dermatologist should know about Polycystic Ovary Syndrome (PCOS)
What every dermatologist should know about Polycystic Ovary Syndrome (PCOS) Kanade Shinkai, MD PhD University of California, San Francisco Associate Professor of Dermatology I have no conflicts of interest
More informationOverview of Reproductive Endocrinology
Overview of Reproductive Endocrinology I have no conflicts of interest to report. Maria Yialamas, MD Female Hypothalamic--Gonadal Axis 15 4 Hormone Secretion in the Normal Menstrual Cycle LH FSH E2, Progesterone,
More informationCREATING A PCOS TREATMENT PLAN. Ricardo Azziz, M.D., M.P.H., M.B.A. Georgia Regents University
CREATING A PCOS TREATMENT PLAN Ricardo Azziz, M.D., M.P.H., M.B.A. Georgia Regents University PCOS: CREATING A TREATMENT PLAN Good treatment plans are based on sound and complete evaluations History of
More informationPCOS Awareness Symposium Atlanta September 24 th, Preventing Diabetes & Cardiovascular Disease in PCOS
PCOS Awareness Symposium Atlanta September 24 th, 2016 Preventing Diabetes & Cardiovascular Disease in PCOS Katherine Sherif, MD Professor & Vice Chair, Department of Medicine Director, Jefferson Women
More informationPolycystic Ovary Syndrome
Polycystic Ovary Syndrome Definition: the diagnostic criteria Evidence of hyperandrogenism, biochemical &/or clinical (hirsutism, acne & male pattern baldness). Ovulatory dysfunction; amenorrhoea; oligomenorrhoea
More information16 YEAR-OLD OBESE FEMALE WITH OLIGOMENORRHEA
16 YEAR-OLD OBESE FEMALE WITH OLIGOMENORRHEA Katie O Sullivan, MD Adult/Pediatric Endocrinology Fellow University of Chicago ENDORAMA Thursday, September 4th, 2014 Disclosures No financial interests. Will
More informationCase. 24 year old female presented to your office complaining of excess hair growth on her face and abdomen. Questions?
Hirsutism Case 24 year old female presented to your office complaining of excess hair growth on her face and abdomen Questions? Started around puberty with gradual progression Irregular menstrual cycle
More information12/27/2013. Kristen Cain, MD FACOG Reproductive Medicine Institute Sanford Health, Fargo ND
Kristen Cain, MD FACOG Reproductive Medicine Institute Sanford Health, Fargo ND 7% of all women 18-45 Obesity 1/3 of all US women Incidence of PCOS is increasing with increase obesity Obesity Irregular
More informationPCOS and Obesity DUB is better treated by OCPs
PCOS and Obesity DUB is better treated by OCPs Dr. Ritu Joshi Senior consultant Fortis escorts Hospital, Jaipur Chairperson Family welfare com. FOGSI (20092012) Vice President FOGSI 2014 Introduction One
More informationPOLYCYSTIC OVARIAN SYNDROME Laura Tatpati, MD Reproductive Endocrinology and Infertility. Based on: ACOG No. 108 Oct 2009; reaffirmed 2015
POLYCYSTIC OVARIAN SYNDROME Laura Tatpati, MD Reproductive Endocrinology and Infertility Based on: ACOG No. 108 Oct 2009; reaffirmed 2015 NO DISCLOSURES PATIENT 26 years old presents with complaint of
More informationPCOS. Kirtly Parker Jones MD
PCOS Kirtly Parker Jones MD OBJECTIVES The participant will be able to use knowledge about ovarian physiology to council perimenarchal women about irregular periods The participant will be able to evaluate
More informationPOLYCYSTIC OVARIAN SYNDROME WHERE WE ARE AT IN 2018
POLYCYSTIC OVARIAN SYNDROME WHERE WE ARE AT IN 2018 PCOS: WHERE WE ARE AT IN 2018 Nancy Arquette, MD Premier Women s Health 6135 Trust Drive #114 Holland, OH 43528 February 3, 2018 Kalahari Resorts ME
More informationAbnormal Uterine Bleeding Case Studies
Case Study 1 Abnormal Uterine Bleeding Case Studies Abigail, a 24 year old female, presents to your office complaining that her menstrual cycles have become a problem. They are now lasting 6 7 days instead
More information13 th Annual Women s Health Day PCOS. Saturday 02/09/2017 Dr Mathias Epee-Bekima O&G Consultant KEMH
13 th Annual Women s Health Day PCOS Saturday 02/09/2017 Dr Mathias Epee-Bekima O&G Consultant KEMH Learning objectives Perform the appropriate investigations in women where there is a clinical suspicion
More informationPOTION OR POISON? MEDICAL TREATMENT ALTERNATIVES TO THE PILL. Lester Ruppersberger, D.O., FACOOG,CNFPI NFP only Gynecologist
POTION OR POISON? MEDICAL TREATMENT ALTERNATIVES TO THE PILL Lester Ruppersberger, D.O., FACOOG,CNFPI NFP only Gynecologist THE PILL Released to US market in 1960 10-15 x dose of hormones in HRT Over 10-14
More informationAmenorrhoea: polycystic ovary syndrome
There is so much we don't know in medicine that could make a difference, and often we focus on the big things, and the little things get forgotten. To highlight some smaller but important issues, we've
More informationPCOS IN ADOLESCENTS: EARLY DETECTION AND INTERVENTION
PCOS IN ADOLESCENTS: EARLY DETECTION AND INTERVENTION R A C H A N A S H A H, M D M S T R A S S I S TA N T P R O F E S S O R O F P E D I AT R I C S D I V I S I O N O F E N D O C R I N O L O G Y A N D D
More informationPolycystic Ovary Syndrome (PCOS):
Polycystic Ovary Syndrome (PCOS): Current diagnosis and treatment Anatte E. Karmon, MD Disclosures- Anatte Karmon, MD No financial relationships to disclose 2 Objectives At the end of this presentation,
More informationObjectives 1. Be able to describe the classic presentation and diagnostic criteria 2. Be able to explain long-term health concerns associated with the diagnosis 3. Understand what basic treatment options
More informationFemale Reproductive Endocrinology
Female Reproductive Endocrinology Dr. Channa Jayasena PhD MRCP FRCPath Clinical Senior Lecturer & Consultant Endocrinologist Department of Gynaecology, Hammersmith Hospital Anovulation is a common cause
More informationROLE OF HORMONAL ASSAY IN DIAGNOSING PCOD DR GAANA SREENIVAS (JSS,MYSURU)
ROLE OF HORMONAL ASSAY IN DIAGNOSING PCOD DR GAANA SREENIVAS (JSS,MYSURU) In 1935, Stein and Leventhal described 7 women with bilateral enlarged PCO, amenorrhea or irregular menses, infertility and masculinizing
More informationWhat is PCOS? PCOS THE CONQUER PCOS E-BOOK. You'll be amazed when you read this...
PCOS What is PCOS? You'll be amazed when you read this... What is PCOS?. Who is at risk? How to get tested? What are the complications. Is there a cure? What are the right ways to eat? What lifestyle changes
More informationDisclosure. Outline. Obesity: Endocrine Issues as the Cause and as the Effect 4/5/2016
Obesity: Endocrine Issues as the Cause and as the Effect Angela Lennon MD Assistant Professor, Pediatrics University of Kansas Medical Center April 22, 2016 Disclosure I have no relevant financial relationships
More informationPolycystic Ovary Syndrome: Cardiovascular Disease risk
PCOS Challenge Atlanta September 16 th, 2017 Polycystic Ovary Syndrome: Cardiovascular Disease risk Katherine Sherif, MD Professor & Vice Chair, Department of Medicine Director, Jefferson Women s Primary
More informationPolycystic Ovary Syndrome diagnosis & management
Polycystic Ovary Syndrome diagnosis & management Dr Roisin Worsley, FRACP Endocrinologist, Jean Hailes at Epworth https://jeanhailes.org.au/contents/docume nts/resources/tools PCOS is a chronic condition
More informationThe Impact of Insulin Resistance on Long-Term Health in PCOS
Saturday, April 16 th, 2016 PCOS Challenge & Thomas Jefferson University PCOS Awareness Symposium Philadelphia The Impact of Insulin Resistance on Long-Term Health in PCOS Katherine Sherif, MD Professor
More informationDiabetes and Cardiovascular Risks in the Polycystic Ovary Syndrome
Diabetes and Cardiovascular Risks in the Polycystic Ovary Syndrome John E. Nestler, M.D. William Branch Porter Professor of Medicine Chair, Department of Internal Medicine Virginia Commonwealth University
More informationPolycystic Ovary Syndrome (PCOS)
Mr Nabil Haddad M. OBSTET, GYNAEC, FRCOG Consultant Gynaecologist Patient Information Polycystic Ovary Syndrome (PCOS) Mr Nabil Haddad Consultant Gynaecologist What is Polycystic Ovary Syndrome (PCOS)?
More informationTitle of Guideline (must include the word Guideline (not protocol, policy, procedure etc)
Title of Guideline (must include the word Guideline (not protocol, policy, procedure etc) Guideline for the Investigation and Management of Polycystic Ovary Syndrome Author: Contact Name and Job Title
More informationProf.Dr. Nabil Lymon Head of Internal Medicine Department
By Prof.Dr. Nabil Lymon Head of Internal Medicine Department Definitions: Hirsutism: Is the presence of terminal hair in androgendependent sites where hair does not normally grow in women. This hair growth
More informationClinical Problems in the Diagnosis and Treatment of PCOS During Adolescence
Clinical Problems in the Diagnosis and Treatment of PCOS During Adolescence R a c h a n a S h a h, M D M S T A s s i s t a n t P r o f e s s o r o f P e d i a t r i c s D i v i s i o n o f E n d o c r
More informationBlood Pressure Measurement (children> 3 yrs)
Blood Pressure Measurement (children> 3 yrs) If initial BP elevated, repeat BP manually 2x and average, then classify Normal BP Systolic and diastolic
More informationPCOS The intersection of sex hormones & metabolism. Educational Objectives. Presenter Disclosure Information. Polycystic Ovary Syndrome
7:45 8:45 am Polycystic Ovary Syndrome: Diagnosis & Management SPEAKER Katherine Sherif, MD Presenter Disclosure Information The following relationships exist related to this presentation: Katherine Sherif,
More informationPrevalence of Polycystic Ovarian Syndrome among urban adolescent girls and young women in Mumbai
Prevalence of Polycystic Ovarian Syndrome among urban adolescent girls and young women in Mumbai Principal Investigator Co- Investigators Consultant Collaborating Hospital Dr. Beena Joshi Dr. Srabani Mukherji
More information2-Hypertrichosis:- Hypertrichosis is the
Hirsutism And Virilization Hirsutism:- Is the development of androgen-dependent dependent terminal body hair in a woman in places in which terminal hair is normally not found, terminal body hairs are the
More informationPolycystic Ovarian Syndrome (PCOS) LOGO
Polycystic Ovarian Syndrome (PCOS) Ma qianhong Ob/Gyn Department LOGO Contents Epidemiology and Definition Pathophysiology, Endocrinological Features Diagnostic Criteria Treatment Prognosis Introduction
More informationPolycystic Ovary Disease: A Common Endocrine Disorder in Women
Polycystic Ovary Disease: A Common Endocrine Disorder in Women Paul Kaplan, M.D. Clinical Professor of Reproductive Endocrinology - OHSU Courtesy Senior Research Associate, Human Physiology University
More informationPolycystic ovary syndrome
Polycystic ovary syndrome Overview Polycystic ovary syndrome (PCOS) is a condition most often characterized by irregular menstrual periods, excess hair growth and obesity, but it can affect women in a
More informationPCOS. Reproductive Gynaecology and Infertility. Dr.Renda Bouzayen MD.FRCSC GREI,OBGYN Dalhousie University
Reproductive Gynaecology and Infertility PCOS Dr.Renda Bouzayen MD.FRCSC GREI,OBGYN Dalhousie University Dr.Hussein Sabban MD. FRCSC PGY6 GREI Dalhousie University Disclosure No conflict of interest Pilot
More informationCARDIOVASCULAR EVENTS IN POLYCYSTIC OVARY SYNDROME
CARDIOVASCULAR EVENTS IN POLYCYSTIC OVARY SYNDROME Enrico Carmina Executive Director & CEO of Androgen Excess & PCOS Society Professor of Endocrinology Department of Health Sciences and Mother and Child
More informationREI CASE(S) Laura L. Tatpati, MD Division of REI, Dept of OB/GYN KUSM - W
REI CASE(S) Laura L. Tatpati, MD Division of REI, Dept of OB/GYN KUSM - W CASE #1 46 year old female presents with complaint of increased facial and abdominal hair growth for 6-8 months. She has had increased
More informationPCOS guidelines: What s relevant to general practice
PCOS guidelines: What s relevant to general Dr David Molloy Medical Director, Queensland Fertility Group International evidence based PCOS guidelines 1st ever internationally endorsed & evidence based
More informationPOLYCYSTıC OVARY SYNDROME (PCOS) New Perspectives. Michel Abou Abdallah, MD. Reproductive Endocrinology
POLYCYSTıC OVARY SYNDROME (PCOS) New Perspectives Michel Abou Abdallah, MD. Reproductive Endocrinology At the conclusion of this presentation, participants should be able to: Appreciate the spectrum of
More informationUPDATE: Women s Health Issues
UPDATE: Women s Health Issues Renee B. Alexis, MD, MBA, MPH, FACOG Associate Professor Department of OBGYN Kiran C. Patel College of Osteopathic Medicine Disclosure of Conflicts of Interest I have no financial
More informationJannet Huang, MD, FRCPC, FACE, ABIHM, CCD, NCMP.
Jannet Huang, MD, FRCPC, FACE, ABIHM, CCD, NCMP. Polycystic Ovarian Syndrome Definition & Diagnosis Clinical Significance: Link to Diabetes and Cardiovascular Risk Management Lifestyle Strategies Pharmacologic
More informationPolycystic Ovary Syndrome
Polycystic Ovary Syndrome Polycystic ovary syndrome (PCOS) is common. It can cause period problems, reduced fertility, excess hair growth, and acne. Many women with PCOS are also overweight. Treatment
More informationPolycystic Ovarian Syndrome: Diagnosis, Preconceptional Management and Health Risks
Polycystic Ovarian Syndrome: Diagnosis, Preconceptional Management and Health Risks Kate D. Schoyer, M.D. May 6, 2016 Objectives To review how to make the diagnosis of Polycystic Ovarian Syndrome (PCOS)
More informationNew PCOS guidelines: What s relevant to general practice
New PCOS guidelines: What s relevant to general practice Dr Michael Costello Fertility Specialist IVF Australia UNSW Royal Hospital for Women Sydney How do we know if something is new? Louvre Museum, Paris
More informationHirsutism - Management
Hirsutism - Management Scenario: Diagnosis of hirsutism How do I know my patient has it? Look for excessive terminal hair in androgen-dependent areas including the face, chest, linea alba, lower back,
More informationDiagnosis and Management of Polycystic Ovary Syndrome During Adolescence: Questions and Controversies
Diagnosis and Management of Polycystic Ovary Syndrome During Adolescence: Questions and Controversies 2017 Illinois-AACE 2017 Annual Meeting October 14, 2017 Learning Objectives 1) Understand the challenges
More informationHyperandrogenism. Dr Jack Biko. MB. BCh (Wits), MMED O & G (Pret), FCOG (SA), Dip Advanced Endoscopic Surgery(Kiel, Germany)
Hyperandrogenism Dr Jack Biko MB. BCh (Wits), MMED O & G (Pret), FCOG (SA), Dip Advanced Endoscopic Surgery(Kiel, Germany) 2012 Hyperandrogenism Excessive production of androgens Adrenal glands main source
More informationPolycystic Ovary Syndrome
What is the polycystic ovary syndrome? Polycystic Ovary Syndrome The polycystic ovary syndrome (PCOS) is a clinical diagnosis characterized by the presence of two or more of the following features: irregular
More informationF REQUENTLY A SKED Q UESTIONS
Polycystic heart, blood vessels, and appearance. Women with PCOS have these characteristics: Ovarian high levels of male hormones, also called androgens an irregular or no menstrual cycle Syndrome may
More informationINSULIN RESISTANCE, POLYCYSTIC OVARIAN SYNDROME An Overview
INSULIN RESISTANCE, POLYCYSTIC OVARIAN SYNDROME An Overview University of PNG School of Medicine & Health Sciences Division of Basic Medical Sciences PBL MBBS III VJ Temple 1 Insulin Resistance: What is
More informationAddressing Practice Gaps in PCOS
Addressing Practice Gaps in PCOS PCOS Challenge September 21, 2014 Ricardo Azziz, MD, MPH, MBA President, Georgia Regents University CEO, Georgia Regents Health System Introduction PCOS research began
More informationDiabetes: Across the Lifespan Friday, October 17, Obesity, Insulin Resistance and Type 2 Diabetes Cardiovascular Risks in Children.
Diabetes: Across the Lifespan Friday, October 17, 2014 Obesity, Insulin Resistance and Type 2 Diabetes Cardiovascular Risks in Children. Don P. Wilson, M.D., FNLA Diplomate, Am Brd of Clinical Lipidology
More informationRotterdam Criteria 9/30/2017. A Changing Paradigm in PCOS. Polycystic Ovary Syndrome - Is the Cardiometabolic Risk Increased After Menopause?
Disclosure Polycystic Ovary Syndrome - Is the Cardiometabolic Risk Increased After Menopause? Fractyl laboratories, Inc Anuja Dokras, MD., Ph.D. Professor of Obstetrics and Gynecology Director PENN PCOS
More informationPolycystic Ovarian Syndrome: Diagnosis, Preconceptional Management and Health Risks. Kate D. Schoyer, M.D. May 6, 2016
Polycystic Ovarian Syndrome: Diagnosis, Preconceptional Management and Health Risks Kate D. Schoyer, M.D. May 6, 2016 Objectives To review how to make the diagnosis of Polycystic Ovarian Syndrome (PCOS)
More informationHirsutism: Diagnosis and Treatment. Roger A. Lobo M.D. Columbia University
Hirsutism: Diagnosis and Treatment Roger A. Lobo M.D. Columbia University Signs of hyperandrogenism Acne, Hirsutism, Alopecia All explained by increased androgen production and/or increased sensitivity
More informationPolycystic Ovary Syndrome Therapy Dr. Pilar Vigil MD, PhD, FACOG
Polycystic Ovary Syndrome Therapy Dr. Pilar Vigil MD, PhD, FACOG What is an ovulatory dysfunction? Mrs. Susana Godoy, Nurse-Midwife San José, Costa Rica Abril 2018 PONTIFICIA UNIVERSIDAD CATÓLICA DE CHILE
More informationTreatment of hirsutism with a gonadotropin-releasing hormone agonist and estrogen replacement therapy*
Gynecology-endocrinology FERTILITY AND STERILITY Copyright 1994 The American Fertility Society Printed on acid-free paper in U S. A. Treatment of hirsutism with a gonadotropin-releasing hormone agonist
More informationManaging polycystic ovary syndrome in primary care
Singapore Med J 2018; 59(11): 567-571 https://doi.org/10.11622/smedj.2018135 CMEArticle Managing polycystic ovary syndrome in primary care Angelyn Chen Yin Lua 1, MBBS, MRCP(UK), Choon How How 2,3, MMed,
More informationX/06/$15.00/0 The Journal of Clinical Endocrinology & Metabolism 91(1):2 6 Copyright 2006 by The Endocrine Society doi: /jc.
0021-972X/06/$15.00/0 The Journal of Clinical Endocrinology & Metabolism 91(1):2 6 Printed in U.S.A. Copyright 2006 by The Endocrine Society doi: 10.1210/jc.2005-1457 EXTENSIVE CLINICAL EXPERIENCE Relative
More informationAchieving Pregnancy: Obesity and Infertility. Jordan Vaughan, MSN, APN, WHNP-BC Women s Health Nurse Practitioner Nashville Fertility Center
Achieving Pregnancy: Obesity and Infertility Jordan Vaughan, MSN, APN, WHNP-BC Women s Health Nurse Practitioner Nashville Fertility Center Disclosures Speakers Bureau EMD Serono Board of Directors Nurse
More informationBy Jennifer F. Teskey, MD; Heather J. Dean, MD, FRCPC; and Elizabeth AC Sellers, MSc, MD, FRCPC. amenorrhea. Following menarche 3. How to treat PCOS.
PCOS & teens: The need for early detection By Jennifer F. Teskey, MD; Heather J. Dean, MD, FRCPC; and Elizabeth AC Sellers, MSc, MD, FRCPC A 15-year-old girl is referred In this article: to the pediatric
More informationUniversity of Cape Town
P a g e 1 The Polycystic Ovary Syndrome a comparison of the presentation in adolescents compared to women aged 35 years and older attending the Gynaecological Endocrine clinic at Groote Schuur Hospital.
More informationWHY NEW DIAGNOSTIC CRITERIA FOR DIFFERENT PCOS PHENOTYPES ARE URGENTLY NEEDED
WHY NEW DIAGNOSTIC CRITERIA FOR DIFFERENT PCOS PHENOTYPES ARE URGENTLY NEEDED Ricardo Azziz, M.D., M.P.H., M.B.A. Chief Officer of Academic Health & Hospital Affairs State University of New York (SUNY)
More informationVol-4 No.-2 July-September 2011
"Women's Health" is also available at www.squarepharma.com.bd Vol-4 No.-2 July-September 2011 Editorial Board Dr. Omar Akramur Rab MBBS, FCGP, FIAGP Mohammad Hanif M. Pharm, MBA A.H.M.Rashidul Bari M.
More informationInfertility for the Primary Care Provider
Infertility for the Primary Care Provider David A. Forstein, DO FACOOG Clinical Associate Professor Obstetrics and Gynecology University of South Carolina School of Medicine Greenville Disclosure I have
More informationThoughts on PCOS Female Androgenization Syndrome FAS
Thoughts on PCOS Female Androgenization Syndrome FAS Stan Korenman, M.D. Distinguished Professor of Medicine-Endocrinology and Associate Dean - Ethics David Geffen School of Medicine at UCLA Conflicts
More informationMetabolic Syndrome. Shon Meek MD, PhD Mayo Clinic Florida Endocrinology
Metabolic Syndrome Shon Meek MD, PhD Mayo Clinic Florida Endocrinology Disclosure No conflict of interest No financial disclosure Does This Patient Have Metabolic Syndrome? 1. Yes 2. No Does This Patient
More informationAbout PCOS. About PCOS
About PCOS About PCOS Polycystic Ovarian Syndrome (PCOS) is the most common hormonal reproductive problem in women of childbearing age. It can affect a woman s menstrual cycle, fertility, hormones, insulin
More informationDifference Between PCOS and Endometriosis
Difference Between PCOS and Endometriosis www.differencebetween.com Key Difference PCOS vs Endometriosis Ovaries play an important role in the reproduction and the maintenance of the female body. They
More informationManagement of polycystic ovarian syndrome
14 Disorders of male and female sex hormones Management of polycystic ovarian syndrome LI-WEI CHO AND STEPHEN L. ATKIN Patients with polycystic ovarian syndrome can be challenging as they usually present
More informationAssisted Reproductive. Technologies: Present and. Future
Assisted Reproductive Technologies: Present and Future Paul Kaplan, M.D. The Assisted Reproductive Technologies (ART) In Vitro Fertilization (IVF) Intracytoplasmic Sperm Injection (IVF/ICSI) Donor Oocyte
More informationStelios Mantis, MD DuPage Medical Group Pediatric Endocrinology
Stelios Mantis, MD DuPage Medical Group Pediatric Endocrinology 4 11 13 Initial Presentation Pt initially presented to pediatrician for school physical in fall 2012. Pt was found to be overweight (BMI:
More informationThe Pharmacology of PCOS
The Pharmacology of PCOS G. Wright Bates, Jr., M.D. Director Reproductive Endocrinology & Infertility University of Alabama at Birmingham Objectives Review the diagnosis of PCOS Highlight lifestyle modifications
More informationJMSCR Vol 05 Issue 05 Page May 2017
www.jmscr.igmpublication.org Impact Factor 5.84 Index Copernicus Value: 83.27 ISSN (e)-2347-176x ISSN (p) 2455-0450 DOI: https://dx.doi.org/10.18535/jmscr/v5i5.14 Hyperinsulinemia in Polycystic Ovary Syndrome
More informationDiagnosis and Management of PCOS
Diagnosis and Management of PCOS Anita L. Nelson, MD Professor Emeritus, Obstetrics & Gynecology, David Geffen School of Medicine at UCLA Clinical Professor Obstetrics & Gynecology, University Southern
More informationPolycystic Ovary Syndrome
Page 1 of 5 Polycystic Ovary Syndrome Polycystic ovary syndrome (PCOS) is common. It can cause period problems, reduced fertility, excess hair growth, and acne. Many women with PCOS are also overweight.
More informationDetermining the insulin resistance rate in Polycystic Ovary Syndrome patients (PCOs)
Abstract: Determining the insulin resistance rate in Polycystic Ovary Syndrome patients (PCOs) Ashraf Olabi, Ghena Alqotini College of medicine, Aleppo University Hospital Obstetrics and Gynacology, Syria.
More informationObjectives 06/21/18 STILL A PLACE FOR PILLS DON T IVF EVERYTHING. Clomiphene citrate and Letrozole. Infertility Case Studies. Unexplained Infertility
STILL A PLACE FOR PILLS DON T IVF EVERYTHING Jeff Roberts M.D. Co-Director, Pacific Centre for Reproductive Medicine Objectives 1 2 3 4 5 Clomiphene citrate and Letrozole Infertility Case Studies Unexplained
More informationNitasha Garg 1 Harkiran Kaur Khaira. About the Author
https://doi.org/10.1007/s13224-017-1082-4 ORIGINAL ARTICLE A Comparative Study on Quantitative Assessment of Blood Flow and Vascularization in Polycystic Ovary Syndrome Patients and Normal Women Using
More informationAdolescents with PCOS in a busy clinical practice: Making the most of your 15 minutes
Financial Disclosures Learning Objectives Adolescents with PCOS in a busy clinical practice: Making the most of your 15 minutes Amy Sass, MD, MPH Adolescent Medicine Patricia Huguelet, MD Pediatric and
More informationDr Mary Birdsall. Fertility Associates Auckland
Dr Mary Birdsall Fertility Associates Auckland Period Problems Mary Birdsall Medical Director Fertility Associates Auckland Period Problems Basic Physiology No Periods Irregular Periods Heavy Periods
More informationThe Egyptian Journal of Hospital Medicine (January 2019) Vol. 74 (1), Page 63-69
The Egyptian Journal of Hospital Medicine (January 2019) Vol. 74 (1), Page 63-69 Effect of Metformin Only versus Effect of Metformin and Corticosteroids after Laparoscopic Ovarian Drilling on Ovulation
More information3. Metformin therapy for PCOS
1. Introduction The key clinical features of polycystic ovary syndrome (PCOS) are hyperandrogenism (hirsutism, acne, alopecia) and menstrual irregularity with associated anovulatory infertility. 1 The
More informationFrom the editors desk
From the editors desk Dear all, We are happy to introduce the first issue of our magazine on hormonal health. This magazine will focus on updates related to common clinical problems in diabetes, thyroid,
More informationInternational Evidence-based Guideline on the Assessment and Management of PCOS 2018: PCOS 2018 Guideline Explained.
International Evidence-based Guideline on the Assessment and Management of PCOS 2018: PCOS 2018 Guideline Explained Michael Costello IVF Australia University of New South Wales (UNSW) Royal Hospital for
More informationReproductive Health and Pituitary Disease
Reproductive Health and Pituitary Disease Janet F. McLaren, MD Assistant Professor Division of Reproductive Endocrinology and Infertility Department of Obstetrics and Gynecology jmclaren@uabmc.edu Objectives
More informationUpdate on PCOS Research. Richard S. Legro, M.D., Penn State College of Medicine, Dept of Ob/Gyn, Hershey, PA, USA
Update on PCOS Research Richard S. Legro, M.D., Penn State College of Medicine, Dept of Ob/Gyn, Hershey, PA, USA Conflicts Consultant: Euroscreen, AstraZeneca, Ferring, Clarus, Kindex, Takeda Funding:
More informationEvaluation and Treatment of Hirsutism in Premenopausal Women: An Endocrine Society* Clinical Practice Guideline
CLINICAL PRACTICE GUIDELINE Evaluation and Treatment of Hirsutism in Premenopausal Women: An Endocrine Society* Clinical Practice Guideline Kathryn A. Martin, 1 R. Rox Anderson, 1 R. Jeffrey Chang, 2 David
More informationUpdate on Polycystic Ovary Syndrome What Dermatology Nurses and Nurse Practitioners Need to Know
FEATURE ARTICLE Update on Polycystic Ovary Syndrome What Dermatology Nurses and Nurse Practitioners Need to Know Rebecca Carron 2.0 Contact Hours ABSTRACT Purpose: Polycystic ovary syndrome is the most
More informationApproach to ovulation induction and superovulation in women with a history of infertility. Anatte E. Karmon, MD
Approach to ovulation induction and superovulation in women with a history of infertility Anatte E. Karmon, MD Disclosures- Anatte Karmon, MD No financial relationships to disclose 2 Objectives At the
More information